Cytion
Private Company
Funding information not available
Overview
Cytion operates as a trusted supplier of authenticated cell lines and cell culture services, catering primarily to academic, biotech, and pharmaceutical researchers. The company differentiates itself through a stringent quality assurance process, guaranteeing cells free from mycoplasma and cross-contamination, and a flexible, customer-centric business model with tailored pricing for commercial and non-profit entities. With a portfolio of over 800 cell lines and services like cell banking and assay-ready cells, Cytion is positioned as a critical infrastructure provider supporting foundational biomedical research and drug discovery.
Technology Platform
A rigorous quality control and authentication platform for biological materials, including cell line authentication, contamination screening (mycoplasma, viruses), and expertise in cell culture expansion and banking.
Opportunities
Risk Factors
Competitive Landscape
Cytion competes in the research cell market against giants like ATCC and MilliporeSigma, as well as numerous niche providers. It differentiates through a strong focus on authentication, contamination-free guarantees, and a customer-centric pricing model tailored for both commercial and non-profit entities.